Mission Statement, Vision, & Core Values of Trevi Therapeutics, Inc. (TRVI)

Ever wondered what drives a biopharmaceutical company focused on tackling chronic cough? What are the guiding principles behind Trevi Therapeutics, Inc. (TRVI), especially as they navigate the complexities of clinical trials and strive to bring innovative therapies to market? With a market cap of $538 million and a stock price of $5.56 as of April 11, 2025, understanding the core values, mission, and vision can offer valuable insights into the company's strategic direction and long-term potential.

What exactly does Trevi Therapeutics aim to achieve, and what values underpin their daily operations and strategic decisions? How do these elements align with their financial activities, such as the reported net loss of $47.9 million for the year ended December 31, 2024, and research and development expenses that reached $11.2 million in Q3 2024 alone?

Dive in to explore the mission statement, vision, and core values that shape Trevi Therapeutics' journey in the biopharmaceutical landscape.

Trevi Therapeutics, Inc. (TRVI) An Overview of

Trevi Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing Haduvio™ (nalbuphine ER) for chronic pruritus, a severe itching condition. While specific sales figures for April 2025 are not available, the company continues to focus on its clinical development programs and potential commercial launch of Haduvio™. Trevi Therapeutics aims to address unmet needs in chronic pruritus and other conditions.

Trevi Therapeutics' financial performance is crucial to understanding its stability and growth potential. As of the latest financial reports, the company's revenue streams are primarily tied to its clinical development programs and potential future sales of Haduvio™. Investors and stakeholders closely monitor these financial metrics to assess the company's ability to sustain operations and achieve its strategic goals. For a detailed analysis, read more here: Breaking Down Trevi Therapeutics, Inc. (TRVI) Financial Health: Key Insights for Investors

Trevi Therapeutics is striving to establish itself as a leader in the biopharmaceutical industry, particularly in the treatment of chronic pruritus. Its focus on innovative solutions and commitment to addressing unmet medical needs drive its strategic initiatives. Here are key aspects that define the company's approach:

• Innovative Pipeline: Developing Haduvio™ and exploring other potential therapies.
• Strategic Focus: Targeting chronic pruritus and related conditions with high unmet needs.
• Clinical Development: Advancing clinical programs to support regulatory approvals and commercialization.

Trevi Therapeutics, Inc. (TRVI) Mission Statement

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for neurologically mediated conditions. Their primary focus is on advancing Haduvio™ (oral nalbuphine ER) for chronic cough in adults with idiopathic pulmonary fibrosis (IPF) and other chronic cough indications, as well as for prurigo nodularis Trevi Therapeutics, Inc. (TRVI): History, Ownership, Mission, How It Works & Makes Money.

The mission is reflected in the words of Jennifer Good, Co-Founder, President & CEO: 'At Trevi Therapeutics, we are dedicated to the development of Haduvio for patients with chronic cough in Idiopathic Pulmonary Fibrosis and Refractory Chronic Cough. Our team is committed to improving patients' lives. Each day, we work with the purpose of making a meaningful impact, focused on delivering a therapy for those affected by chronic cough.'

Here's a breakdown of the core components of Trevi Therapeutics' mission:

• Focus on Haduvio Development: The company is dedicated to the development of Haduvio for chronic cough.
• Targeting Specific Patient Populations: Specifically, they aim to help patients with Idiopathic Pulmonary Fibrosis (IPF) and Refractory Chronic Cough (RCC).
• Commitment to Improving Lives: The team is committed to making a meaningful impact on patients' lives.
• Purpose-Driven Work: Each day, they work with the purpose of delivering a therapy for those affected by chronic cough.

Trevi Therapeutics is passionate about progress. They are focused on developing Haduvio™ (oral nalbuphine ER) to help patients suffering from chronic cough by targeting the central and peripheral cough reflex arc.

Trevi Therapeutics reported a net loss of $11.4 million for the fourth quarter of 2024, compared to a net loss of $7.8 million in the same period in 2023. For the year ended December 31, 2024, the Company reported a net loss of $47.9 million, compared to a net loss of $29.1 million for the same period in 2023.

Research and development (R&D) expenses for the fourth quarter of 2024 increased to $9.3 million from $6.5 million in the same period in 2023, primarily due to increased clinical development expenses for the Phase 2b CORAL trial, the Phase 2a RIVER trial, and the HAP study, as well as an increase in personnel-related expenses.

General and administrative (G&A) expenses for the fourth quarter of 2024 increased to $2.9 million from $2.4 million in the same period in 2023, primarily due to an increase in stock-based compensation expense and personnel-related expenses.

Trevi Therapeutics ended 2024 with $107.6 million in cash, cash equivalents and marketable securities, with expected cash runway into the second half of 2026.

As of April 11, 2025, Trevi Therapeutics's stock price is $5.56. Its current market cap is $538M with 96.7M shares.

Trevi Therapeutics, Inc. (TRVI) Vision Statement of

To fully understand the direction and guiding principles of Trevi Therapeutics, Inc., it's crucial to examine its mission statement, vision, and core values. These elements provide a clear picture of the company’s objectives and how it aims to achieve them. Trevi Therapeutics is focused on developing innovative treatments for chronic conditions, particularly those with limited therapeutic options. Understanding these guiding statements helps stakeholders assess the company's strategic alignment and potential for future success.

Mission Statement

Trevi Therapeutics, Inc. is dedicated to developing and commercializing innovative therapies for chronic and debilitating conditions. Their primary focus is on addressing unmet medical needs, particularly in patients suffering from severe pruritus, or chronic itch, and other chronic conditions. The company aims to improve the quality of life for these patients by providing effective and safe treatment options.

• Focus on Unmet Needs: Addressing conditions where current treatments are inadequate.
• Innovative Therapies: Developing new and effective solutions.
• Improved Quality of Life: Enhancing the well-being of patients.

Vision Statement

While a specific, publicly declared vision statement for Trevi Therapeutics, Inc. is not readily available, we can infer their vision from their actions and strategic goals. Trevi's vision is likely centered around becoming a leading biopharmaceutical company recognized for its novel treatments for chronic conditions. This includes expanding their pipeline and achieving commercial success with Haduvio™ (nalbuphine ER) and future products.

Key aspects of their implied vision include:

• Leadership in Innovation: Being at the forefront of developing new therapies.
• Expanding Treatment Options: Offering a range of solutions for chronic conditions.
• Commercial Success: Successfully marketing and distributing their products.

Core Values

Trevi Therapeutics' core values are reflected in their commitment to patients, innovation, and scientific rigor. Although not explicitly listed, these values can be discerned from their operational focus and corporate communications.

Inferred core values include:

• Patient-Centricity: Prioritizing the needs and well-being of patients.
• Innovation: Fostering a culture of creativity and scientific advancement.
• Integrity: Maintaining high ethical standards in research and business practices.
• Collaboration: Working effectively with partners and stakeholders.

These values drive their approach to drug development and patient care. For instance, the development of Haduvio™ demonstrates their commitment to addressing unmet needs in chronic pruritus. Investors can gain additional insights into the company's financial strategy and health by visiting: Breaking Down Trevi Therapeutics, Inc. (TRVI) Financial Health: Key Insights for Investors

Trevi Therapeutics, Inc. (TRVI) Core Values of

As of April 2025, Company operates with a set of core values that guide its actions and decisions. While specific details of these values may evolve, Company is dedicated to making a difference in the lives of patients.

Here are some of the Company's potential core values:

Focus on Patients

Company places patients at the center of its mission, striving to improve their lives through innovative therapies. This commitment is reflected in every aspect of their work, from research and development to clinical trials and patient support programs.

• Clinical Trials: Company prioritizes patient safety and well-being in all clinical trials.
• Patient Advocacy: Company actively engages with patient advocacy groups to understand their needs and address their concerns.

Innovation

Company fosters a culture of innovation, encouraging employees to think creatively and challenge the status quo. By embracing new ideas and technologies, Company aims to develop groundbreaking treatments that address unmet medical needs.

• Research and Development: Company invests heavily in research and development to discover and develop novel therapies.
• Technological Advancement: Company leverages cutting-edge technologies to improve the efficiency and effectiveness of its drug development process.

Integrity

Company operates with the highest ethical standards, ensuring transparency, honesty, and accountability in all its interactions. This commitment to integrity builds trust with patients, healthcare professionals, and stakeholders.

• Compliance: Company adheres to all applicable laws, regulations, and industry standards.
• Ethical Conduct: Company promotes a culture of ethical conduct, encouraging employees to make decisions that are in the best interests of patients and stakeholders.

Collaboration

Company recognizes the importance of collaboration in achieving its goals. By working together with partners, researchers, and patient communities, Company can leverage diverse expertise and resources to accelerate the development of new therapies.

• Partnerships: Company actively seeks partnerships with other organizations to expand its reach and impact.
• Community Engagement: Company engages with local communities to support health initiatives and promote awareness of its therapeutic areas.

Excellence

Company strives for excellence in all aspects of its operations, from scientific research to commercial execution. By setting high standards and continuously improving its processes, Company aims to deliver exceptional value to patients and stakeholders.

• Quality Assurance: Company maintains rigorous quality control standards to ensure the safety and efficacy of its products.
• Continuous Improvement: Company is committed to continuously improving its processes and performance to achieve the highest levels of excellence.

To explore Company's history, mission, and business model, check out this resource: Trevi Therapeutics, Inc. (TRVI): History, Ownership, Mission, How It Works & Makes Money